1. < Osteoporosis & Bone Health
Profile picture for bone9lady

bisphosphonates Update by FDA

Posted by bone9lady @bone9lady, Apr 4 12:03pm

I have been on and off Fosamax for several years. As of Feb. 2026, the FDA has updated the safety labels for bisphosphonate medications to include a warning that atypical fractures can occur in bones other than the femur. These include the ulna (arm) and tibia (lower leg). The updated warning includes fosamax, reclast, actenol, Boniva. The warning is for those on bisphosphonates longer than 5 years. I just happen to come upon the update or I wouldn't have been aware of it. I'll be discussing it with my endocrinologist. There is no need to panic but knowledge is everything!

Interested in more discussions like this? Go to the Osteoporosis & Bone Health Support Group.

Profile picture for daisy17
daisy17 | @daisy17 | 2 days ago
In reply to @suehall "@daisy17 Okay, that's interesting. Has he listened to you, read these articles, and told you why?..." + (show)
Profile picture for suehall @suehall

@daisy17
Okay, that's interesting. Has he listened to you, read these articles, and told you why? Great to have a doc who shows respect.

Jump to this post

@suehall I mentioned the articles and he said the information "wasn't true" and Fosamax still had benefit. I didn't have the articles with me to show him. I asked him if other women refused the drugs and he said "yes", they were worried about the side effects.

REPLY
Profile picture for suehall
suehall | @suehall | 2 days ago

At least he told you that others have refused the drugs for the same reason.

It would be great if he could provide evidence that explains why he said the info isn't true--we all need more info.

I'm meeting with my PCP this week to discuss all this (asking for a referral to a nutritionist because my appt with endocrinologist isn't for several months). Will report back.

REPLY
View MoreView Less
Please sign in or register to post a reply.